- $53.65m
- -$46.08m
- $9.85m
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems
Kronos rises after disclosing plan to lay off 83% of employees
Brief: Kronos Bio Says Norbert Bischofberger Resigns As President & CEO
Brief: Kronos Bio Says Norbert Bischofberger Steps Down As President & CEO
Brief: Kronos Bio Approves 83% Workforce Reduction As Part Of A Strategic Resource Allocation And Cost Containment Plan
U.S. RESEARCH ROUNDUP-Cisco, Freshpet, Nvidia
Kronos Bio Inc reports results for the quarter ended September 30 - Earnings Summary
Kronos Bio Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Kronos Bio Q3 EPS USD -0.23
Kronos Bio Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Kronos Bio Says Receives Non-Compliance Notice From Nasdaq - SEC Filing
Brief: Kronos Bio Files For Mixed Shelf Of Up To $250 Million - SEC Filing
Brief: Kronos Bio Announces Selection Of Autoimmune Development Candidate For Sjögren’s Disease
Kronos Bio Inc reports results for the quarter ended in June - Earnings Summary
Brief: Kronos Bio Q2 Operating Expenses USD 20.711 Million
Kronos Bio Inc expected to post a loss of 34 cents a share - Earnings Preview